Turacoz Group Introduces AI-Driven Living Systematic Reviews at World EPA Congress 2025

Turacoz Group Champions AI in Evidence Synthesis at World EPA Congress 2025

At the highly anticipated World Evidence, Pricing, and Access (EPA) Congress 2025 held in Utrecht, Netherlands, Turacoz Group presented its pioneering advancements in the field of evidence synthesis through AI-driven platforms. This event gathered leading professionals from the healthcare sector to collaborate and discuss emerging strategies in market access and innovations in evidence application.

Transformative Presentation by Dr. Namrata Singh
Among the notable highlights was the presentation by Dr. Namrata Singh, Founder and CEO of Turacoz Group, who eloquently spoke on the topic “Revolutionizing Evidence Synthesis – The Role of Artificial Intelligence in Living Systematic Reviews (LSRs).” This framework's significance was prominently illustrated by a scientific poster detailing AI-driven methodologies that underscores Turacoz’s dedication to advancing the field of structured evidence gathering.

Dr. Singh’s discourse illustrated how innovations in machine learning and automation are reshaping the methodology of evidence synthesis. She elaborated on the potential of these technologies to provide real-time updates on research literature and improve the efficacy of healthcare decision-making processes. During her presentation, findings from a healthcare professional (HCP) survey were shared, exploring varying levels of understanding and application of living publications within practice.

Revolutionizing Healthcare Data Insights
As the landscape of healthcare continuously evolves, the demand for accurate and timely data has never been more pressing. Turacoz Group’s AI-powered systematic literature reviews, bias detection algorithms, and adaptive meta-analyses are not just innovative; they are essential tools that are transforming post-market surveillance, health technology assessments (HTAs), and comparative effectiveness research (CER). These advancements are geared towards enhancing both the efficiency and reliability of healthcare insights, thereby supporting informed decision-making across the entire industry.

Dr. Singh underlined the critical importance of AI in modern evidence-based medicine, stating, "In an era of rapid advancements and vast data sources, it is essential to develop innovative methodologies for gathering, synthesizing, and disseminating high-quality evidence. AI-powered solutions enhance accuracy, timeliness, and accessibility, empowering healthcare professionals to make well-informed, data-driven decisions that improve patient care and drive scientific progress."

A Commitment to Innovation and Quality
Utilizing its formidable expertise in AI-driven real-world evidence (RWE) and health economics and outcomes research (HEOR), Turacoz provides unparalleled strategic support in real-world data analytics, efficient systematic reviews, comprehensive medical writing, and detailed regulatory submissions. By generating high-quality evidence and engaging in extensive health economics research, Turacoz aids organizations in navigating complex healthcare environments, thereby illustrating the profound value and impact of various medical interventions.

With a commitment to innovation, Turacoz Group strives to empower pharmaceutical, biotechnology, and healthcare stakeholders, facilitating data-driven decisions that lead to improved patient outcomes, enhanced healthcare efficiencies, and optimized market access strategies.

About Turacoz Group

Turacoz Group partners with biopharmaceutical companies, medical technology firms, healthcare professionals, and research institutions to provide expert guidance in product and service development. With a focus on clear, cohesive, complete, concise, and concrete scientific communication, Turacoz ensures that intricate data is effectively articulated across multiple formats, both in print and digitally. Their extensive knowledge in RWE and HEOR further enables the provision of AI-driven insights, systematic reviews, and real-world data analyses that empower clients to make evidence-based choices that drive innovation, enhance patient care, and optimize market strategies.